Lobeglitazone Recruiting Phase 4 Trials for Type 2 Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02338921Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy
NCT02315287Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes Management